StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the stock. Moleculin Biotech Stock Performance Shares of Moleculin Biotech stock opened at $0.48 on Friday. The firm has a market cap of $14.43 million, a P/E ratio […]
More Stories
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $18.60 Consensus Target Price from Brokerages
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been assigned a consensus recommendation of “Hold” from the...
Brokerages Set Canadian National Railway Company (NYSE:CNI) Price Target at $120.86
Shares of Canadian National Railway Company (NYSE:CNI – Get Free Report) (TSE:CNR) have received an average recommendation of “Moderate Buy”...
Q1 EPS Estimates for Legend Biotech Raised by HC Wainwright
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) – Analysts at HC Wainwright raised their Q1 2026 earnings per...
What is Leerink Partnrs’ Estimate for ELAN FY2025 Earnings?
Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) – Equities researchers at Leerink Partnrs raised their FY2025 earnings estimates for...
Scotiabank Raises Earnings Estimates for Freeport-McMoRan
Freeport-McMoRan Inc. (NYSE:FCX – Free Report) – Equities research analysts at Scotiabank raised their FY2025 earnings per share (EPS) estimates...
Q4 EPS Estimate for L3Harris Technologies Lifted by Analyst
L3Harris Technologies Inc (NYSE:LHX – Free Report) – Equities researchers at Seaport Res Ptn raised their Q4 2025 earnings estimates...